NCT00304616View on ClinicalTrials.gov

SWitching to Abilify Trial (SWAT)

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

October 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole, Solian, Olanzapine, Seroquel, Risperidone

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY